Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis

M. K. Han
European Respiratory Journal 2006 28: 884-885; DOI: 10.1183/09031936.06.00071806
M. K. Han
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

To the Editors:

The role of gastro-oesophageal reflux in idiopathic pulmonary fibrosis (IPF) has been given little consideration in the literature, and Raghu et al. 1 have made a significant contribution in this regard. However, if we examine their data in terms of attributable risk, the potential clinical impact of these findings becomes even clearer.

Several other reports have suggested a possible link between gastro-oesophageal reflux and IPF. A case–control study from 1976 determined the prevalence of reflux to be higher in 48 patients with IPF than in 270 age-matched controls with fibrosis of other aetiologies 2. Tobin et al. 3 previously published a smaller case–control study which identified that 16 out of 17 (94%) patients with IPF compared with four out of eight (50%) patients with interstitial lung disease due to other causes had abnormal acid exposure in the oesophagus. In 2005, Patti et al. 4 determined the prevalence of gastro-oesophageal reflux in IPF patients to be 66%, with a third of those patients having no reflux symptoms.

In the current study, 46 patients with IPF not currently receiving proton pump inhibitor (PPI) therapy were compared with 133 asthmatics also not receiving PPI therapy. All patients were subjected to 24-h pH-probe testing. The prevalence of abnormal acid exposure was 87 and 68% in IPF patients and asthmatics, respectively (statistically significant, p = 0.014). Thus, the odds of having IPF in those with abnormal acid exposure as compared to those without (odds ratio) is 3.19. The attributable risk percentage (ARP) calculated based on table 1⇓, which was constructed using data from the study by Raghu et al. 1, is 68.6%. If we assume a causal relationship between reflux and IPF, then simply stated the ARP means that 68.6% of the cases of IPF in patients with abnormal acid exposure would not have occurred in the absence of exposure. The population ARP is 49.8%, which means that in the population of patients studied, almost half of IPF cases identified would not have occurred in the absence of abnormal acid exposure.

View this table:
  • View inline
  • View popup
Table 1—

Frequency of gastro-oesophageal reflux in patients with IPF and asthma

Unfortunately, the data presented by Raghu et al. 1 also suggest that only 47% of patients with abnormal acid exposure experienced gastrointestinal symptoms, meaning that symptom-targeted therapy may not be effective. Given the relatively low cost of proton pump inhibitor therapy and low side-effect profile compared with other available therapies for idiopathic pulmonary fibrosis, these data suggest that at the very least treatment with a proton pump inhibitor should be strongly considered in patients with idiopathic pulmonary fibrosis until better data are available. The data presented by Raghu et al. 1 also showed that 12 out of 19 patients on proton pump inhibitors still had abnormal results from pH-probe studies. More research needs to be carried out regarding the association between reflux and idiopathic pulmonary fibrosis to determine whether even more aggressive therapies should be considered, should treatment with proton pump inhibitors fail to adequately treat reflux.

    • © ERS Journals Ltd

    References

    1. ↵
      Raghu G, Freudenberger TD, Yang S, et al. High prevalence of abnormal gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J 2006;27:136–142.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976;69:512–515.
      OpenUrlCrossRefPubMedWeb of Science
    3. Tobin RW, Pope CE 2nd, Pellegrini CA, Emonda MJ, Sillery J, Raghu G. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;158:1804–1808.
      OpenUrlCrossRefPubMedWeb of Science
    4. ↵
      Patti MC, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic. J Gastrointest Surg 2005;9:1053–1056.
      OpenUrlCrossRefPubMedWeb of Science
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 28 Issue 4 Table of Contents
    European Respiratory Journal: 28 (4)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
    M. K. Han
    European Respiratory Journal Oct 2006, 28 (4) 884-885; DOI: 10.1183/09031936.06.00071806

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
    M. K. Han
    European Respiratory Journal Oct 2006, 28 (4) 884-885; DOI: 10.1183/09031936.06.00071806
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • References
    • Figures & Data
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Clinical outcomes of bronchiectasis in India
    • Reply: Clinical outcomes of bronchiectasis in India
    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society